Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Immunogenicity of candidate DNA vaccine based on subtype A of human immunodeficiency virus type 1 predominant in Russia. / Murashev, Boris; Kazennova, Elena; Kozlov, Alexander; Murasheva, Irina; Dukhovlinova, Elena; Galachyants, Yuri; Dorofeeva, Ekaterina; Dukhovlinov, Ilya; Smirnova, Galina; Masharsky, Alexey; Klimov, Nikolay; Kozlov, Andrei P.
в: Biotechnology Journal, Том 2, № 7, 01.07.2007, стр. 871-878.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Immunogenicity of candidate DNA vaccine based on subtype A of human immunodeficiency virus type 1 predominant in Russia
AU - Murashev, Boris
AU - Kazennova, Elena
AU - Kozlov, Alexander
AU - Murasheva, Irina
AU - Dukhovlinova, Elena
AU - Galachyants, Yuri
AU - Dorofeeva, Ekaterina
AU - Dukhovlinov, Ilya
AU - Smirnova, Galina
AU - Masharsky, Alexey
AU - Klimov, Nikolay
AU - Kozlov, Andrei P.
PY - 2007/7/1
Y1 - 2007/7/1
N2 - Human immunodeficiency virus (HIV)-1 subtype A strains circulating among the majority of HIV-infected individuals in the former Soviet Union (FSU) countries demonstrate low genetic diversity. The consensus sequence of the FSU region-specific isolate has been used for the candidate DNA vaccine development. We constructed recombinant plasmids with four viral genes: env (gp140), gag, pol (reverse transcriptase), and nef. We immunized BALB/c mice intramuscularly using equimolar mixture of four recombinant plasmids, and observed significant cytotoxic T lymphocyte response and specific CD8+ cell production against cells presenting HIV-1 peptides. Overall, the Th1 pathway of immune response clearly dominated. Immunological properties of this candidate DNA vaccine against HIV-1 suggest the possibility of its further study in clinical trials.
AB - Human immunodeficiency virus (HIV)-1 subtype A strains circulating among the majority of HIV-infected individuals in the former Soviet Union (FSU) countries demonstrate low genetic diversity. The consensus sequence of the FSU region-specific isolate has been used for the candidate DNA vaccine development. We constructed recombinant plasmids with four viral genes: env (gp140), gag, pol (reverse transcriptase), and nef. We immunized BALB/c mice intramuscularly using equimolar mixture of four recombinant plasmids, and observed significant cytotoxic T lymphocyte response and specific CD8+ cell production against cells presenting HIV-1 peptides. Overall, the Th1 pathway of immune response clearly dominated. Immunological properties of this candidate DNA vaccine against HIV-1 suggest the possibility of its further study in clinical trials.
KW - DNA vaccine
KW - Flow cytometry-based CTL assay
KW - H2-D-restricted CTL epitopes
KW - HIV-1 subtype A
KW - Intracellular cytokine staining
UR - http://www.scopus.com/inward/record.url?scp=34547470055&partnerID=8YFLogxK
U2 - 10.1002/biot.200700024
DO - 10.1002/biot.200700024
M3 - Article
C2 - 17582822
AN - SCOPUS:34547470055
VL - 2
SP - 871
EP - 878
JO - Biotechnology Journal
JF - Biotechnology Journal
SN - 1860-6768
IS - 7
ER -
ID: 37699242